SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001193125-12-084271
Filing Date
2012-02-28
Accepted
2012-02-28 12:54:57
Documents
12
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 40-F/A d305707d40fa.htm 40-F/A 21047
2 EXHIBIT 99.1 d305707dex991.htm EX-99.1 517932
3 EXHIBIT 99.3 d305707dex993.htm EX-99.3 10107
4 EXHIBIT 99.4 d305707dex994.htm EX-99.4 9951
5 EXHIBIT 99.5 d305707dex995.htm EX-99.5 4292
6 EXHIBIT 99.6 d305707dex996.htm EX-99.6 4245
7 EXHIBIT 99.7 d305707dex997.htm EX-99.7 13974
8 EXHIBIT 99.8 d305707dex998.htm EX-99.8 14001
9 GRAPHIC g305707ex991_pg01.jpg GRAPHIC 10670
10 GRAPHIC g305707page11_1sta.jpg GRAPHIC 5046
11 GRAPHIC g305707page11_2nd.jpg GRAPHIC 1090
12 GRAPHIC g305707page11_3rd.jpg GRAPHIC 1554
  Complete submission text file 0001193125-12-084271.txt   622468
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 40-F/A | Act: 34 | File No.: 001-35203 | Film No.: 12645729
SIC: 2834 Pharmaceutical Preparations